Table 1 miR-182 expression and clinicopathological characteristics of prostate cancer patients
From: Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans
|  | tissue (n=82) | miR-182 (mean±SD) | P value |
|---|---|---|---|
PSA (<10; >10) | |||
 <10 | 55 | 1.145±0.774 | 0.030 |
 >10 | 27 | 2.090±0.402 |  |
European-american | 42 | 1.087±0.750 | 0.017 |
African-american | 40 | 1.844±1.806 |  |
Biochemical recurrence | |||
 No | 39 | 1.270±1.380 | 0.278 |
 Yes | 27 | 1.678±1.636 |  |
Age | |||
 <65 | 44 | 1.216±0.911 | 0.061 |
 ≥65 | 38 | 1.877±1.947 |  |
T-classification | |||
 T2 | 47 | 1.125±0.824 | 0.096 |
 T3/T4 | 21 | 1.507±0.946 |  |
Gleason | |||
 Grade1/Grade2 | 51 | 1.138±0.995 | 0.060 |
 Grade3/Grade4/Grade5 | 23 | 2.040±2.114 |  |